TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | -5 | -11 | 24 | -14 | 8 | 0 |
| P | %wins | 50 | 50 | 0 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/23/18 12:34 | 8/22/18 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Maslowski John Michael | PA | DO | CEO | P | 6 | 2.06 | 0 | 3 | 999% | 3 | D | ||||||||||||||
8/12/15 16:08 | 8/11/15 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Maslowski John Michael | PA | O | VP,Scien | P | 6 | 6.33 | 3 | 1 | 68 | 2 | D | 12 | 97 | 62 | 77 | 20 | -4 | -3 | -6 | -5 | -12 | -18 | -26 | -78 | -94 |
11/21/14 16:04 | 11/20/14 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Maslowski John Michael | PA | O | VP,Scien | P | 3 | 2.54 | 0 | 1 | 208 | 1 | D | -46 | -30 | -10 | -16 | -10 | -9 | -6 | -4 | 0 | 3 | -3 | 74 | 51 | 110 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |